** Shares of Firebrick Pharma FRE.AX slide as much as 10%
to A$0.18, their lowest level on record
** Says it raised A$1 million via a share placement at
A$0.15 per share
** Issue price represents a 25% discount to the shares' last
closing price of A$0.20
** Funds raised to support phase 3 clinical trials for
Nasodine, a nasal spray to treat colds, among others
** Stock records worst intraday pct drop since Feb. 21
** As of last close, shares down 13% YTD
(Reporting by Harshita Swaminathan)
((Harshita.Swaminathan@thomsonreuters.com))